<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0370512</journal-id>
<journal-id journal-id-type="pubmed-jr-id">457</journal-id>
<journal-id journal-id-type="nlm-ta">Am J Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">Am J Psychiatry</journal-id>
<journal-title-group>
<journal-title>The American journal of psychiatry</journal-title>
</journal-title-group>
<issn pub-type="ppub">0002-953X</issn>
<issn pub-type="epub">1535-7228</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28253736</article-id>
<article-id pub-id-type="pmc">5578709</article-id>
<article-id pub-id-type="doi">10.1176/appi.ajp.2017.16101115</article-id>
<article-id pub-id-type="manuscript">NIHMS900769</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Identification of Developmental and Behavioral Markers Associated with Genetic Abnormalities in Autism Spectrum Disorder</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Bishop</surname>
<given-names>Somer L.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Farmer</surname>
<given-names>Cristan</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bal</surname>
<given-names>Vanessa</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Robinson</surname>
<given-names>Elise</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Willsey</surname>
<given-names>A. Jeremy</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Werling</surname>
<given-names>Donna M.</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Havdahl</surname>
<given-names>Karoline Alexandra</given-names>
</name>
<degrees>M.S.</degrees>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sanders</surname>
<given-names>Stephan J.</given-names>
</name>
<degrees>M.D., Ph.D.</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thurm</surname>
<given-names>Audrey</given-names>
</name>
<degrees>Ph.D.</degrees>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Psychiatry, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA</aff>
<aff id="A2">
<label>2</label>Pediatrics &amp; Developmental Neuroscience Branch, National Institute of Mental Health, Bethesda, MD</aff>
<aff id="A3">
<label>3</label>Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA</aff>
<aff id="A4">
<label>4</label>Stanley Center for Psychiatric Research and Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, Cambridge, MA</aff>
<aff id="A5">
<label>5</label>Integrative Epidemiology Unit, University of Bristol, UK</aff>
<author-notes>
<corresp id="FN1">CORRESPONDING AUTHOR: Somer L. Bishop, Ph.D., UCSF Weill Institute for Neurosciences, 401 Parnassus Avenue, San Francisco, CA 94143, <email>Somer.Bishop@ucsf.edu</email>, Phone: 415-502-3349</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>21</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>3</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<day>01</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>31</day>
<month>8</month>
<year>2017</year>
</pub-date>
<volume>174</volume>
<issue>6</issue>
<fpage>576</fpage>
<lpage>585</lpage>
<!--elocation-id from pubmed: 10.1176/appi.ajp.2017.16101115-->
<abstract>
<sec id="S1">
<title>Objective</title>
<p id="P1">Aside from features associated with risk of neurogenetic syndromes in general (e.g., cognitive impairment), limited progress has been made in identifying phenotype-genotype relationships in autism spectrum disorder (ASD).</p>
</sec>
<sec id="S2">
<title>Method</title>
<p id="P2">This study extends work in the Simons Simplex Collection (SSC) by comparing the phenotypic profiles of ASD probands with or without identified <italic>de novo</italic> loss of function mutations (LoF) or Copy Number Variants (CNV) in high confidence ASD-associated genes/loci (Sanders et al., 2015). Analyses pre-emptively accounted for documented differences in sex and IQ in affected individuals with <italic>de novo</italic> mutations, by matching probands with and without these genetic events on sex, IQ, and age before comparing them on multiple behavioral domains.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Children with <italic>de novo</italic> mutations (<italic>n</italic>=112) showed greater likelihood of motor delays during early development (i.e., later age of walking), but <italic>less</italic> impairment in certain measures of ASD core symptoms (parent-rated social-communication impairment and clinician-rated diagnostic certainty) in later childhood. These children also showed relative strengths in verbal and language abilities, including a smaller discrepancy between nonverbal and verbal IQ and a greater likelihood of having achieved fluent language.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">Children with ASD with <italic>de novo</italic> mutations may exhibit a “muted” symptom profile with respect to social-communication and language deficits, relative to those with ASD with no identified genetic abnormalities. Such findings suggest that examining early milestone differences and standardized testing results may be helpful in etiologic efforts, and potentially in clinical differentiation of various subtypes of ASD, but only if developmental/demographic variables are properly accounted for first.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>